During the past decade, Consultants in Medical Oncology and Hematology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Consultants in Medical Oncology and Hematology" #1 collaborator was "Exelixis" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Consultants in Medical Oncology and Hematology" are "Carcinoma, Non-Small-Cell Lung" (1 trials), "KEAP1 Gene Mutation" (1 trials), "NFE2L2 Gene Mutation" (1 trials), "NRF2 Mutation" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Consultants in Medical Oncology and Hematology" in a lesser frequency.

Most popular intervention types in "Consultants in Medical Oncology and Hematology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Alectinib" (1 trials), "Belvarafenib" (1 trials), "Cabozantinib" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Consultants in Medical Oncology and Hematology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Consultants in Medical Oncology and Hematology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Consultants in Medical Oncology and Hematology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Consultants in Medical Oncology and Hematology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".